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Abstract 
The cornea is the outermost layer of the eye and is a vital component of focusing incoming light on the 
retina. Central corneal thickness (CCT) is now recognized to have a significant role in ocular health and is 
a risk factor for various ocular diseases, such as keratoconus and primary open angle glaucoma. Most 
previous genetic studies utilized European and Asian subjects to identify genetic loci associated with 
CCT. Minority populations, such as Latinos, may aid in identifying additional loci and improve our 
understanding of the genetic architecture of CCT. In this study, we conducted a genome-wide association 
study (GWAS) in Latinos, a traditionally understudied population in genetic research, to further identify 
loci contributing to CCT. Study participants were genotyped using either the Illumina OmniExpress 
BeadChip (~730K markers) or the Illumina Hispanic/SOL BeadChip (~2.5 million markers). All study 
participants were 40 years of age and older. We assessed the association between individual single 
nucleotide polymorphisms (SNPs) and CCT using linear regression, adjusting for age, gender, and 
principal components of genetic ancestry. To expand genomic coverage and to interrogate additional 
SNPs, we imputed SNPs from the 1000 Genomes Project reference panels. We identified a novel SNP, 
rs10453441 (P = 6.01E-09), in an intron of WNT7B that is associated with CCT. Furthermore, WNT7B is 
expressed in the human cornea. We also replicated 11 previously reported loci, including IBTK, RXRA-
COL5A1, COL5A1, FOXO1, LRRK1, and ZNF469 (P < 1.25E-3). These findings provide further insight 
into the genetic architecture of CCT and illustrate that the use of minority groups in GWAS will help 
identify additional loci. 
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Introduction 
The cornea is the clear, outermost layer of the eye that aids in refracting incoming light onto the lens, 
which is then further refocused onto the retina. Compared to the lens, the cornea has greater refractive 
power and thus, is a critical ocular structure to focus light on the retina. Due to the large refractive power, 
any structural variations of the cornea (i.e. smoothness, curvature, or thickness) may result in adverse 
effects on vision. Mounting evidence suggests central corneal thickness (CCT) plays a significant factor 
in ocular health. Thin CCT has been observed in several visual disorders, including brittle cornea 
syndrome, keratoconus, and osteogenesis imperfecta (1-3). CCT is also an important endophenotype for 
primary open angle glaucoma (POAG). Most notably, thin CCT has been found to be associated with 
POAG in multiple epidemiologic studies (4-10). Therefore, understanding the factors that influence CCT 
may help to better predict CCT and potentially, POAG. 
Ethnic differences in CCT have been observed in several studies. Generally, Hispanics have slightly 
higher CCT measurements than Caucasians, while individuals of African descent exhibit the lowest CCT, 
and CCT from Asian populations representing a wide range of values (7, 11-13). While environmental 
factors may contribute to the observed racial variation, genetic variants specific to certain ethnic 
populations are more likely to have a major role in CCT determination (14). Moreover, CCT is a highly 
heritable trait, with heritability ranging from 0.60 to 0.95 (15, 16). Taken together, these findings suggest 
that the primary factors determining CCT are genetic rather than environmental. 
Recently, genome-wide association studies (GWAS) have identified numerous genetic loci that are 
associated with CCT in various ethnic populations. These GWAS, conducted in European, Asian, and 
Latino populations, have identified single nucleotide polymorphisms (SNPs) in or nearby AKAP13 (17, 
18), COL5A1 (18, 19), COL8A2 (19), FAM53B (20), FOXO1 (20), IBTK (17), LRRK1 (17), RXRA-
COL5A1 (18, 19, 21, 22), and ZNF469 (18-21) to be associated with CCT. A meta-analysis consisting of 
a large number of European and Asian individuals identified 16 additional loci associated with CCT, 
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including LPAR1 and ARID5B (23). Furthermore, we reported the first GWAS on CCT in Latinos and 
replicated previously reported loci, as well as identified novel SNPs (22). 
While genetic loci associated with CCT have consistently been identified, these loci have primarily been 
found in populations of European and Asian descent. We hypothesize performing GWAS in minority 
populations may identify new loci associated with CCT, as well as elucidate the racial differences of 
CCT. Latinos, the largest minority group in the United States, are traditionally an understudied population 
among genetic studies. Furthermore, Latinos exhibit thicker CCT compared to other ethnic groups. Taken 
together, identifying novel genetic variants associated with CCT in Latinos may elucidate racial 
differences and further our understanding of the genetic architecture of CCT. Therefore, the purpose of 
this study is to conduct a larger GWAS using Latino subjects to identify novel genetic loci for CCT. To 
our knowledge, this is the largest GWAS for CCT conducted in a Latino population. 
Results 
Study Sample 
The descriptive statistics of the study sample are presented in Table 1. Overall, a total of 4,515 individuals 
were used to assess the associations between SNPs and CCT, of which 3,584 unrelated individuals were 
used as a discovery set and 931 related individuals were used in a replication set. The overall mean age 
(standard deviation) is 54.8 (10.5), with the discovery set and replication set having mean ages of 54.2 
(9.9) and 56.9 (12.5), respectively. The proportion of females in the study sample is 58.8%, with the 
discovery set composed of 56.5% women and the replication set composed of 68.0% women. Combined, 
the CCT values are normally distributed with an overall mean of 550.0 (33.4) µm, with the average of the 
discovery and replicate sets as 550.4 (33.2) µm (range: 443-668) and 548.7 (34.0) µm (range: 451 - 661), 
respectively. 
Genome-Wide Association Results 
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The genomic control (GC) inflation factor, λ, was 1.05, after adjusting for age, gender, and principal 
components of genetic ancestry. A Q-Q plot was generated and is presented in Supplementary Figure 1. 
Upon visual inspection of the plot, the observed –log10(P values) do not deviate from the null, except at 
the extreme tail. This plot suggests proper control of population stratification in this Latino sample. 
Figure 1 presents a Manhattan plot displaying the discovery set SNP association P values for the 576, 798 
SNPs included in this analysis. Table 2 summarizes the SNPs, rs3118515, rs12447690, and rs10453441, 
that reached genome-wide significance (P < 5 × 10
-8
) during the discovery set analysis. Among these 
three SNPs, all have previously been associated with CCT except for rs10453441, which is a novel 
finding in this study. rs10453441 (P = 3.14 × 10
-8
, GRCh37/hg19 position 46,363,739, chromosome 22) 
is located in an intron of the WNT7B gene (wingless-type MMTV integration site family, member 7B). 
The minor allele G (MAF = 0.455) is associated with a reduction in CCT (β = -4.51). rs3118515 (P = 1.16 
× 10
-8
, GRCh37/hg19 position 137,436,314) resides in the uncharacterized gene LOC100506532, which is 
situated 86.5 kb 3’ of the RXRA gene (retinoid X receptor, alpha) and 96.5 kb 5’ of the COL5A1 gene 
(collagen, type V, alpha 1) on chromosome 9. The minor allele of rs3118515, A (MAF = 0.268), is 
associated with a reduction in CCT (β = -5.15). rs12447690 (P = 9.16 × 10
-9
, GRCh37/hg19 position 
88,298,124) is located 195 kb upstream of the ZNF469 gene (zinc finger protein 469) and 187 kb 
downstream of the BANP gene (BTG3 associated nuclear protein) on chromosome 16. The minor allele of 
rs12447690 C (MAF = 0.360) is associated with a reduction in CCT per allele copy (β = -4.86). 
For the replication set, we analyzed the top SNPs using a set of related individuals and adjusted for the 
relatedness among individuals using linear mixed-effects models. All three of the SNPs showed similar 
directionality of the effect estimates for the minor alleles, compared to the discovery set (Table 2). 
rs10453441 was significant (P = 0.03) in our replicate set. The meta-analysis of the discovery and 
replication sets strengthened the association for rs10453441, P = 6.01 × 10
-9
. Therefore, rs10453441 
represents a novel genetic locus associated with CCT in Latinos. Furthermore, rs10453441 was associated 
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with CCT in our Indian consanguineous pedigree dataset (240 individuals from 16 pedigrees, P = 
5.85×10
-4
) (24), providing another replication for the novel discovery. Similarly, the association result for 
SNP rs3118515 was also strengthened after the meta-analysis, P = 9.29 × 10
-11
. 
Results From Imputed SNPs 
To expand genomic coverage and further identify additional genetic loci associated with CCT, we used 
the maximum number of unrelated individuals (n = 4,038), including unrelated individuals from the 
replication set, to analyze imputed SNPs. The GC λ for the imputed dataset was 1.05. Analysis of imputed 
SNPs did not identify any additional GWAS loci for CCT stronger than directly genotyped SNPs. The 
SNP rs10453441 was the only significant SNP associated with CCT on chromosome 22 for genotyped 
and imputed SNPs (Rsq ≥ 0.80). Figure 2 presents the regional SNP association plots for the WNT7B 
regions. Genotyped and imputed SNPs are plotted as squares and circles, respectively. 
Analysis of Previously Reported Loci for CCT 
We evaluated 52 previously reported SNPs that reached genome-wide significance (P < 5×10
-8
) in 
European and Asian populations to determine whether these associations were consistent in a Latino 
population. The results are summarized in Table 3. Of the 52 previously reported SNPs, 51 SNPs were 
either directly genotyped or imputed well and among these SNPs, a majority of SNPs had a P < 0.05 
(38/51 = 75%). Furthermore, in our Latino population, all except one SNP exhibited consistent 
directionality of the effect with these previously reported SNPs. To account for multiple testing among 
correlated SNPs, we employed simpleM (25, 26) to estimate the number of independent tests for the 51 
SNPs. This method identified 40 independent tests, resulting in a Bonferroni corrected P value of 
0.00125. Using this corrected P value, we replicated 28 SNPs in the following 11 loci, NR3C2, IBTK, 
C7orf42, LPAR1, RXRA-COL5A1, COL5A1, LCN12-PTGDS, ARHGAP20-POU2AF1, FOXO1, LRRK1, 
and ZNF469 regions (boldface P values in Table 3). We were, however, unable to replicate previous 
index SNPs in other regions, including COL8A2, COL4A3, FAM53B, SMAD3, and AKAP13. Intriguingly, 
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a study conducted in individuals of European ancestry was unable to replicate several of these 
associations (27); however, this later study was restricted to NEIGHBOR and GLAUGEN POAG cases 
and controls, suggesting that not all CCT loci are POAG related. 
Biological Evidence 
The WNT7B gene has been reported to be expressed in the human cornea (28) and the mouse cornea (29). 
WNT7B was upregulated in the human central cornea and is specific to the mature corneal epithelium (28) 
and was mainly expressed in the endothelial cell layer in the mouse cornea (29). Genevestigator (see Web 
Resources), an online database to verify gene expression in different tissue types, also shows that WNT7B 
is highly expressed in normal human corneas (Supplementary Figure 2). 
Pathway Analysis 
Table 4 summarizes the top five canonical pathways from IPA and KEGG pathways from WebGestalt 
through gene-set association testing of directly genotyped SNPs. The most significantly enriched 
canonical pathway is 14-3-3-mediated signaling (P = 2.9E-03), followed by the IGF-1 signaling (P = 
2.9E-03), myc mediated apoptosis signaling (P = 6.45E-03), neuregulin signaling (P = 6.45E-03), and 
NGF signaling (P = 3.8E-02) pathways, respectively. The top pathway, 14-3-3-mediated signaling, is a 
family of proteins that are involved in cell cycle, apoptosis, and protein trafficking and the presence of 
14-3-3 proteins have been reported in the human cornea (30). Similarly, the Myc mediated apoptosis 
signaling pathway is related to the cell cycle and may have a role in maintaining the homeostasis of the 
corneal epithelium. The IGF-1 signaling, neuregulin signaling, and NGF signaling pathways involve 
growth factors and IGF-1 (31), neuregulin 1 (32), and NGF (33) have been reported to have a biological 
effect in human corneas. In addition, the top KEGG pathways are metabolic pathways (P = 7.27E-06), 
ErbB signaling pathway (P = 2.95E-05), tight junction (P = 1.0E-04), pathways in cancer (P = 1.0E-04), 
and T cell receptor signaling pathway (P = 8.0E-04). The ErbB family consists of receptor tyrosine 
kinases that regulates various biological responses, including cell proliferation, differentiation, migration, 
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and carcinogenesis, and this family has been shown to play a role in corneal epithelial wound healing 
(34). Tight junctions are composed of proteins that mediate cell adhesion and serve as diffusion barriers 
with the tight junction-related proteins occludin, claudin, and ZO-1 expressed in human corneal 
epithelium (35). And lastly, genes that have been studied in tumor metastasis models were also found to 
be differentially expressed in the cornea (36). Interestingly, during both wound healing and cancer 
development, related cells exhibit rapid proliferation and tissue remodeling (36). Taken together, our 
pathway analysis results from IPA and KEGG yielded comparable pathways with regard to the cornea in 
that the programs identified pathways relevant to cellular proliferation, migration, and apoptosis, 
suggesting such pathways may have a role in the integrity and homeostasis of the human cornea. 
Discussion 
This study is the largest GWAS conducted in Latinos for CCT. We identified rs10453441 in the WNT7B 
gene on chromosome 22 as a novel SNP for CCT. Furthermore, one previously reported SNP on 
chromosome 9, rs3118515, and one previously reported SNP on chromosome 16 rs12447690 also reached 
genome-wide significance. These SNPs were replicated at the 0.05 significance level (one-sided P values 
being computed with regard to the direction of effect found in the discovery set) in our Latino replication 
set, except for rs12447690. The association of rs10453441 with CCT was also replicated in an Indian 
dataset (P = 5.85×10
-4
) (24). We were also able to replicate 11 previous GWAS loci, such as variants in 
the RXRA-COL5A1, COL5A1, IBTK, FOXO1, LRRK1, and ZNF469 regions. Though genotype imputation 
using the 1KGP increased the number of SNPs in our dataset, we did not identify additional GWAS loci 
for CCT in the imputed dataset. As further support, the WNT7B gene is expressed in the human cornea, 
which provides biological evidence for its association with CCT. 
The novel SNP identified here associated with CCT, rs10453441 is located in the genomic region that 
includes WNT7B, a member of the WNT gene family, a group of structurally related genes that encode 
secreted signaling proteins. This SNP has previously been positively associated with axial length and 
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corneal curvature, ocular parameters related to myopia, in a GWAS among Asian and Caucasian 
populations (29). These investigators further identified a positive association between this SNP and 
extreme myopia, as well as localized WNT7B expression in the endothelial cell layer of mouse cornea and 
the downregulation of this gene in extreme myopia. Compared to Miyake et al. (2014), where rs10453441 
was associated with an increase in both axial length and corneal curvature, our results identified its 
association with CCT. CCT is not highly correlated with either axial length or corneal curvature (37), 
suggesting rs10453441 may influence different ocular phenotypes in different ethnic groups. 
As a member of Wnt signaling and one of 19 Wnt proteins, WNT7B was found to be upregulated in the 
central cornea of humans and the Wnt signaling pathway may have a role in primary limbal stem cell 
proliferation (28). Similarly, various other components of Wnt signaling have previously been implicated 
in the cornea. Wnt4 has been detected in the basal and immediate parabasal limbal epithelial cells in both 
normal fetal and adult human corneas (38). Additionally, during corneal wound healing, Wnt7a was 
found to promote the proliferation of corneal epithelial cells (39). The results from our study suggest 
rs10453441 may play an important role in CCT determination, independent of axial length and corneal 
curvature, and similar to other members of Wnt signaling, WNT7B may have an active biological role in 
regulating CCT. 
Our study has many strengths, including the use of the largest Latino dataset containing both ophthalmic 
and genotyped data thus far. We conducted a two stage GWAS, using both population- and family-based 
study designs to replicate associated loci. Our sample size was able to achieve 80% power to detect 
variants with MAF 0.455 explaining 1% (like rs10453441) of trait variation (two sided test, αp= 5×10
-8
,
calculated by Quanto (40, 41)). We imputed and analyzed SNPs from the 1KGP to extend genomic 
coverage to further identify common variants not directly genotyped, using a specialized imputation 
protocol for Latino populations (42). Both the imputed and genotyped GWAS results are presented in the 
supplementary data. We also carried out imputation using our own Hispanic/SOL data as the reference 
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panel and analyzed these SNPs using linear mixed models, though we did not identify any additional new 
loci for CCT (data not shown). Gene expression analysis provided biological support for the expression of 
the WNT7B gene in the cornea. This study, however, also has some limitations. Latinos are historically 
understudied in genetic research. Despite the largest Latino data for studying ophthalmic phenotypes, our 
sample size is limited compared to meta-analyses using European and Asian subjects. We emphasize the 
need to replicate our findings in an independent Latino cohort. Variants of smaller effects may also not be 
detected. The effect size estimates of GWAS hits may suffer from the winner’s curse (43, 44). For 
example, the bias-corrected beta for rs12447690 in the discovery set was -4.14 with a confidence interval 
[-2.06, -8.34] calculated using BR-squared software (45) via 1,000 bootstrap re-sampling. Due to the 
three-way admixture (the ancestral composition of this sample is shown in Supplementary Figure 3), it is 
generally more challenging to impute in Latinos (42). The imputation quality of the WNT7B region on 
chromosome 22 was low, which can mask other possible interesting SNPs, e.g. rs9330813 (P = 5.14×10
-8
) 
and rs10453458 (P = 1.29×10
-8
) only had imputation scores of Rsq = 0.74 and 0.56, respectively. 
Chromosome 22 has previously been shown to be difficult to impute for Latinos (42). As reference panels 
and imputation technologies continue to improve for Latinos, the ability to impute and consequently, 
identify associations with non-directly genotyped SNPs, may improve as well. We investigated 
association for the top SNP (rs10453441) in 5 independent European CCT studies, but did not observe 
consistent association with this SNP and CCT in these populations (Supplementary Table 1). This 
suggests that rs10453441 may not be generalized to the European populations. But it is also possible that 
the association in the European populations was mitigated by suboptimal imputation quality. 
Furthermore, we are genotyping our entire cohort using the Illumina HumanExome BeadChip through 
MAGGS. As our genotyping progresses, we will have more power to uncover additional loci. 
In summary, we identified a novel genome-wide significant association between rs10453441 in WNT7B 
and CCT in the largest GWAS of CCT in Latinos. We also replicated previously reported SNPs identified 
in other ethnic groups. Furthermore, our pathway analysis identified relevant pathways associated with 
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apoptosis and cell development for CCT. Our results suggest GWAS conducted in minority populations 
can identify additional loci associated with CCT not previously identified in GWAS or large-scale meta-
analyses using European or Asian populations and may aid in furthering our understanding of ethnic 
differences of CCT, as well as elucidating the genetic architecture of CCT. 
Materials and Methods 
Ethics Statement 
The following research was approved by the University of Illinois at Chicago, the University of Southern 
California Health Sciences Campus, and the Los Angeles Biomedical Research Institute at Harbor-
University of California, Los Angeles, (UCLA) institutional review boards. All clinical investigation was 
conducted according to the principles expressed in the Declaration of Helsinki. 
Study Sample 
We conducted this research using data collected from the Los Angeles Latino Eye Study (LALES), the 
largest population-based study of visual impairment and ophthalmic diseases conducted among 6,357 
Latinos living in six census tracts in the city of La Puente, Los Angeles County, California. All subjects 
included in this study were 40 years of age and older and written, informed consent was obtained from 
each study participant. 
Measurement of CCT 
All study participants underwent a detailed ophthalmologic examination. Three CCT measurements were 
obtained in each eye using a commercial ultrasonic computation module (A-scan/pachymeter DGH 
4000B SBH IOL Computation Module; DGH Tech, Inc., Exton, PA) during examination. The three CCT 
measurements were averaged to obtain a single value in each eye. The average CCT measurement for the 
left and right eyes was taken to yield the final CCT value. If CCT measurements were available for only 
one eye, this value was used as a surrogate for the final CCT measurement. 
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Genotyping and Quality Control 
We genotyped a total of 4,996 Latinos through LALES and the Mexican American Glaucoma Genetic 
Study (MAGGS) using either the Illumina OmniExpress BeadChip Kit (730, 525 markers; Illumina, Inc., 
San Diego, CA; n = 4,278) or the Illumina Hispanic/SOL BeadChip (~2.5 million markers; Illumina, Inc., 
San Diego, CA; n = 718). The genotyping for this study was performed at the Genotyping Laboratory of 
the Institute for Translational Genomics and Population Sciences at the Los Angeles Biomedical Research 
Institute at Harbor-UCLA. SNPs were called using the software Illumina GenomeStudio (v2011.1; 
Illumina, Inc.). Study participants whose genotyping call rate was less than 97% were excluded from 
further analysis. Additionally, study participants with gender inconsistency between reported and 
genetically inferred gender, missing CCT measurements, CCT outliers, and duplicates were removed. 
After removal of these study subjects, 4,515 subjects remained for downstream analysis, of which 3,584 
unrelated individuals were used as a discovery set (stage 1) and 931 first-degree relatives (416 families) 
were used as a replication set (stage 2). The program PLINK (v1.90) was used to perform quality control 
on the genotype data (46). SNPs that overlapped between the genotyping chips were retained for analysis 
and were further excluded if the minor allele frequency (MAF) < 1%, the call rate < 95%, or the Hardy-
Weinberg equilibrium P values < 10
-6
. After the above quality control parameters, 576,798 SNPs 
remained for further analysis. SNPs were coded on the forward strand to facilitate the imputation process. 
Genotype Imputation 
To increase genomic coverage, we used Shapeit2 (47), Minimac3 (see Web Resources), and the 1000 
Genomes Project (1KGP) reference panels to perform genotype imputation to integrate additional SNPs 
that were not directly genotyped. Both Minimac3 and the 1KGP Phase 1v3 haplotype reference panels 
were downloaded from the Center for Statistical Genetics at the University of Michigan (see Web 
Resources). The 1KGP reference panels used for imputation contain a large number of variants, 39.7 
million variants, increasing the ability to interrogate non-genotyped SNPs through the use of linkage 
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disequilibrium (LD). Due to the unique ancestral populations of Latinos, we used the AMR+CEU+YRI 
reference panels (a combination of Colombian, Mexican, Puerto Rican, CEPH, and Yoruba haplotypes), 
which we have previously shown to have the highest genotype imputation accuracy for Latinos (42). 
We phased our genotypes using Shapeit2 and carried out genotype imputation using Minimac3 on the 
phased data. Genotypes that were imputed were coded as allelic dosages (estimated counts ranging from 0 
to 2). Quality control parameters were applied to filter out low quality imputed SNPs, i.e. Rsq < 0.80 and 
MAF < 1%. After removal of low quality imputed SNPs, 6,844,888 imputed SNPs remained for further 
analysis. 
Statistical Analysis 
The program EIGENSOFT was used to infer principal components of genetic ancestry (48). To make 
inferences of known ancestral populations, we included reference panels of unrelated Northern Europeans 
(CEU, n = 87) and West Africans (YRI, n = 88) from the 1000 Genomes Project (49), and Native 
Americans (n = 105) (50). The first four principal components were retained and were included as 
covariates during linear regression. The genomic control inflation factor (51) was calculated and applied 
and a quantile-quantile (Q-Q) plot was generated to visually inspect the distribution of test statistics. For 
the discovery set, we used PLINK to test the association between individual SNPs and CCT using linear 
regression, adjusting for age, gender, and principal components, assuming an additive genetic effects 
model (46). For the replication set, the association between SNPs and CCT was assessed using a linear 
mixed-effects model (Proc Mixed procedure of SAS v9.4; SAS Institute, Cary, NC), adjusting for age, 
gender, and principal components of genetic ancestry. The compound symmetry covariance structure and 
the empirical “sandwich” estimator were used. Fixed-effects meta-analysis for the discovery and 
replication sets was conducted in METAL using inverse-variance weighting (52). Accounting for 
genotype uncertainty, allelic dosages of imputed SNPs were analyzed using the software mach2qtl (see 
Web Resources). The conventional SNP P value significance threshold of 5 ×10
-8
 was used to declare 
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genome-wide significant SNPs. We applied the simpleM (25, 26, 53) method for multiple testing 
correction to evaluate previously reported loci. The software R (54) and LocusZoom (hg19 / 1KGP AMR) 
(55) were used for graphing. 
Pathway Analysis 
To investigate the contribution of combined genetic effects on the underlying biological processes 
influencing CCT, we performed gene-based and pathway analysis on the maximum number of unrelated 
individuals using SKAT-O (56), QIAGEN’s Ingenuity Pathway Analysis (IPA) (see Web Resources), and 
WEB-based GEne SeT AnaLysis Toolkit (WebGestalt) (57). Using all directly genotyped SNPs, we 
assigned these SNPs to genes according to genomic position based on the hg19 assembly. Moreover, in 
order to capture proximal regulatory and other functional elements occurring outside of a gene, we 
extended the gene boundaries to include SNPs ± 10kb of a gene. SNPs occurring in multiple gene 
boundaries were included in these boundaries separately. Similar to the GWAS model, the gene-set 
associations were further adjusted for age, gender, and principal components of genetic ancestry. 
Enrichment of canonical pathways and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways 
with genes associated with CCT was analyzed using IPA and WebGestalt. Canonical pathways and 
KEGG pathways with a P value < 0.05 after Benjamini-Hochberg multiple testing adjustment (58) were 
declared significantly enriched. The top five most enriched canonical pathways from IPA and KEGG 
pathways from WebGestalt are reported. 
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Web Resources 
The URLs for downloaded data and programs: 
1000 Genomes Project Phase 1v3 haplotypes, 
http://csg.sph.umich.edu/abecasis/MACH/download/1000G.2012-03-14.html 
EIGENSOFT, 
https://genetics.med.harvard.edu/reich/Reich_Lab/Software.html 
Genevestigator, 
https://genevestigator.com/ 
mach2qtl, 
http://csg.sph.umich.edu/abecasis/MACH/download/ 
METAL 
http://csg.sph.umich.edu/abecasis/Metal/download/ 
Minimac3, 
http://genome.sph.umich.edu/wiki/Minimac3#Download 
PLINK, 
https://www.cog-genomics.org/plink2 
QIAGEN, 
http://www.ingenuity.com/products/ipa/ 
simpleM, 
http://simplem.sourceforge.net 
WebGestalt,  
http://bioinfo.vanderbilt.edu/webgestalt/ 
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Figure legends 
Figure 1. A Manhattan plot presenting the –log10(P values) for the 576,798 SNPs included in the 
discovery set (stage 1) plotted by genomic position 
The red horizontal dotted line indicates the genome-wide significance level of P = 5.00 × 10
-8
. Loci 
previously associated with CCT are shown in grey (LOC100506532 and ZNF469) and the novel locus is 
shown in black (WNT7B). 
Figure 2. Regional SNP association plot for rs10453441 
The most significant SNP, using the maximum number of unrelated individuals, is plotted in purple. The 
lead SNP, rs10453441 (P = 7.15 × 10
-9
), remained the most significantly associated in the WNT7B gene. 
Genotyped and imputed SNPs are plotted as squares and circles, respectively. Color-coding of SNPs 
represents the level of linkage disequilibrium with the most significant SNP, rs10453441. Genes in the 
region are shown below the SNPs with arrows indicating the strand orientation. 
Supplementary Figure 1. Quantile-Quantile (Q-Q) plot of the genome-wide P values 
For the 576, 798 SNPs that passed quality control filters in the discovery set, –log10(P values) is plotted 
against the corresponding expected –log10(P values). The genomic control inflation factor λ = 1.05.
Supplementary Figure 2. Expression of WNT7B in various tissues from Genevestigator 
The boxplot-list displays the WNT7B gene expression in 62 postmortem healthy human anatomical parts, 
ranked by the level of expression. WNT7B is highly expressed in the human cornea (n = 6). 
Supplementary Figure 3. Ancestral composition of our Latino sample. 
The first two dimensions from principal component analysis of our Latino subjects are shown along with 
three ancestral populations. Abbreviations: NA, Native Americans; CEU, CEPH in Utah residents; YRI, 
Yoruba in Ibadan, Nigeria. 
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Table 1. Descriptive Statistics of the Study Sample 
Study Sample Size Females, % Age (y), Mean (SD) CCT (µm), Mean (SD) CCT (µm) Range 
Discovery Set (stage 1) 3,584 56.5 54.2  (9.9) 550.4 (33.2) 443-668 
Replication Set (stage 2)  931 68.0  56.9 (12.5) 548.7 (34.0) 451-661 
Total 4,515 58.8  54.8 (10.5) 550.0 (33.4) 443-668 
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Table 2. Single nucleotide polymorphisms significantly associated (P < 5 × 10
-8
) with CCT in Latinos. 
Discovery Replication Meta-Analysis 
P SNP Chr Position Gene A1/A2 AF1 β P β P
*
rs3118515  9 137,436,314 LOC100506532, RXRA, COL5A1 A/G 0.268 -5.15 1.16E-08 -6.41 3.03E-04 9.29E-11 
rs12447690 16  88,298,124 BANP, ZNF469 C/T 0.360 -4.86 9.16E-09 -1.03 0.27 1.81E-08 
rs10453441 22  46,363,739 WNT7B G/A 0.455 -4.51 3.14E-08 -2.95 0.03 6.01E-09 
Abbreviations: Chr, chromosome; A1/A2, allele 1/allele 2; AF1, allele 1 frequency. β models the expected change in mean CCT per increase of 
one A1 allele. Gene name is in boldface if the SNP is inside the gene. SNP positions are according to GRCh37/hg19. 
*
One-sided P values computed with regard to the direction of effect found in the discovery set. 
50
51
52
53
54
55
56
57
58
59
60
24
Table 3. Comparison with previously reported SNPs associated with CCT 
Previously Reported Latinos 
SNP ID Chr Position Genes Nearby 
Effect 
Allele Freq  β Reference(s) A1/A2 AF1  β P Imputed 
Consistency 
of Direction 
rs3767703 1 36555758 COL8A2 −4.43 (19) C/T 0.93 -0.03 9.81E-01 NA 
rs7550047 1 36567343 COL8A2 −4.42 (19) A/G 0.91 0.88 5.00E-01 Y NA 
rs96067 1 36571920 COL8A2 −4.80 (19) G/A 0.38 -1.15 1.29E-01 NA 
rs10189064 2 219327500 USP37 A/G 0.04 −0.19 (23) A/G - - - NA NA 
rs7606754 2 228135180 COL4A3 A/G 0.35 −0.07 (23) A/G 0.41 -0.79 2.91E-01 Y Y 
rs3749260 3 98250862 GPR15 A/C 0.13 −0.12 (23) A/C 0.14 1.76 1.12E-01 Y N 
rs9822953 3 156472071 TIPARP T/C 0.67 0.08 (23) T/C 0.74 1.81 3.51E-02 Y Y 
rs4894535 3 171995605 FNDC3B T/C 0.17 −0.10 (23) T/C 0.25 -2.16 1.09E-02 Y 
rs7620503 3 177304298 TBL1XR1-KCNMB2 T/C 0.39 −0.06 (23) T/C 0.44 -1.18 1.16E-01 Y Y 
rs3931397 4 149079497 NR3C2 T/G 0.07 −0.12 (23) T/G 0.06 -6.77 1.28E-05 Y Y 
rs1117707 5 64389665 CWC27-ADAMTS6 A/G 0.7 −0.11 (23) A/G 0.55 -0.59 4.26E-01 Y Y 
rs1538138 6 82794594 IBTK T 0.18–0.30 −4.23 (17) T/C 0.14 -3.53 7.16E-04 Y 
rs11763147 7 65326821 VKORC1L1 A/G 0.45 0.07 (23) A/G 0.45 1.62 2.85E-02 Y 
rs4718428 7 66421446 C7orf42 G 0.46–0.74 −3.18 (17) G/T 0.45 -2.89 1.89E-04 Y Y 
rs1324183 9 13557491 9p23 A 0.21–0.27 −3.37 (17) A/C 0.14 -2.86 1.15E-02 Y Y 
rs1007000 9 113662681 LPAR1 T/C 0.22 0.07 (23) T/C 0.30 3.43 1.62E-05 Y 
rs1409832 9 137428425 RXRA-COL5A1 −3.95 (19) T/G 0.76 4.32 7.11E-07 NA 
rs4842044 9 137431904 RXRA-COL5A1 −4.67 (19) C/T 0.47 -4.14 2.25E-08 Y NA 
rs1536478 9 137432248 RXRA-COL5A1 −4.63 (19) G/A 0.47 -4.17 2.03E-08 Y NA 
rs3118516 9 137439792 RXRA-COL5A1 A 0.34 −0.15 (21) A/G 0.26 -4.91 5.89E-07 Y* Y 
rs3132306 9 137440212 RXRA-COL5A1 T 0.66 0.15 (21) T/C 0.72 4.83 7.63E-07 Y* Y 
rs1536482 9 137440528 RXRA-COL5A1 G 0.34 0.22 
(18),(21) (A, Freq  
= 0.33, β = −0.15) G/A 0.71 5.21 5.47E-08 Y* Y 
rs7044529 9 137568051 COL5A1 (19) C/T 0.78 3.23 2.58E-04 NA 
rs11145951 9 139860264 LCN12-PTGDS T/C 0.49 0.09 (23) T/C 0.44 3.26 1.15E-05 Y 
rs7090871 10 63830286 ARID5B T/C 0.59 0.06 (23) T/C 0.71 1.40 8.75E-02 Y Y 
rs1006368 10 126346603 FAM53B A/G (20) C/T 0.80 -2.01 2.59E-02 Y NA 
rs11245330 10 126380338 FAM53B A/G (20) A/G 0.20 2.10 1.96E-02 NA 
rs4938174 11 110913240 ARHGAP20-POU2AF1 A/G 0.31 0.06 (23) A/G 0.20 3.34 2.97E-04 Y 
rs1564892 12 104445742 Near GLT8D2 (5') A/G 0.76 −0.08 (23) A/G 0.74 -0.37 6.66E-01 Y Y 
rs1034200 13 23228691 FGF9-FTHL7 0.14 (18) C/A 0.75 -1.69 5.06E-02 NA 
rs2755237 13 41109429 FOXO1 A/C (20) A/C 0.86 3.62 6.45E-04 NA 
rs2721051 13 41110884 FOXO1 A/G (20) C/T 0.92 4.24 1.89E-03 NA 
rs785422 15 30173885 Near TJP1 (5') T/C 0.11 −0.14 (23) T/C 0.07 -3.24 2.66E-02 Y 
rs12913547 15 67467507 SMAD3 T/C 0.77 −0.08 (23) T/C 0.71 -0.44 5.87E-01 Y 
rs6496932 15 85825567 PDE8A-AKAP13 0.13 (18) C/A 0.77 1.53 8.32E-02 NA 
rs1828481 15 85840912 AKAP13 C 0.45–0.56 3.12 (17) C/A 0.49 1.88 1.21E-02 Y NA 
rs7172789 15 85843517 AKAP13 C 0.45–0.56 3.14 (17) C/T 0.48 1.72 2.14E-02 Y 
rs930847 15 101558562 LRRK1 G 0.17–0.39 3.72 (17) G/T 0.19 3.97 2.79E-05 Y 
rs4965359 15 101585336 LRRK1 A 0.40–0.67 −3.50 (17) A/G 0.54 -3.77 4.32E-07 Y Y 
rs12447690 16 88298124 ZNF469 T/C 0.17 
(20),(19),(18) (G,  
β = −0.18), (21) (T, 
Freq = 0.64, β = 
0.16) T/C 0.64 4.14 1.18E-07 Y 
rs7500824 16 88299491 ZNF469 A 0.36 −0.16 (21) A/G 0.24 -4.70 6.35E-07 Y Y 
rs7405095 16 88307825 ZNF469 A 0.36 −0.16 (21) A/G 0.20 -6.02 1.87E-07 Y* Y 
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rs7501109 16 88320862 ZNF469 C 0.64 0.16 (21) C/G 0.80 4.95 2.15E-06 Y* Y 
rs7501402 16 88320911 ZNF469 A 0.36 −0.16 (21) A/T 0.36 -4.38 2.94E-07 Y Y 
rs6540223 16 88321436 ZNF469 T 0.64 0.16 (21) T/C 0.80 4.96 2.22E-06 Y* Y 
rs12448211 16 88330513 ZNF469 A 0.62 0.16 (21) A/G 0.65 4.51 3.89E-08 Y Y 
rs9938149 16 88331640 ZNF469 A/C 
(20),(19),(21) (A,  
Freq = 0.62, β = 
0.16) A/C 0.79 4.56 3.62E-07 Y 
rs9922572 16 88334112 ZNF469 A 0.34 −0.14 (21) A/C 0.20 -4.82 2.01E-06 Y Y 
rs9925231 16 88338107 ZNF469 −4.79 (19) T/C 0.33 -4.37 4.33E-07 Y NA 
rs7204132 16 88344517 ZNF469 −4.95 (19) T/G 0.18 -4.32 4.35E-05 Y NA 
rs9927272 16 88346709 ZNF469 −3.95 (19) G/A 0.34 -2.72 5.68E-04 NA 
rs2323457 17 14554190 HS3ST3B1-PMP22 A/C 0.29 −0.07 (23) A/C 0.40 -0.89 2.32E-01 Y Y 
Abbreviations: Chr, chromosome; Freq, frequency; A1/A2, allele 1 / allele 2. For previously reported SNPs with multiple references, additional 
information on the allele, frequency, and effect size is given in parentheses. For this Latino population, the frequency for allele 1 is given and is 
modeled as the effect allele. The program simpleM was used as a multiple testing correction method for correlated SNPs, identifying 40 
independent tests and thus, giving a Bonferroni correction P value of 0.05/40 = 0.00125. P values meeting this threshold are shown in bold. The 
direction of effect was consistent for most SNPs, except rs3749260. SNP positions are according to GRCh37/hg19. 
*SNPs with suboptimal Rsq (0.62 < Rsq < 0.78).
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Table 4. Top pathways associated with CCT in Latinos 
Pathway Observed / Total Genes P Adjusted P
Ŧ
 
IPA 
14-3-3-mediated Signaling 19/117 1.30E-05 2.9E-03 
IGF-1 Signaling 17/97 1.31E-05 2.9E-03 
Myc Mediated Apoptosis Signaling 12/58 4.47E-05 6.45E-03 
Neuregulin Signaling 15/88 5.81E-05 6.45E-03 
NGF Signaling 15/107 5.38E-04 3.8E-02 
WebGestalt 
Metabolic Pathways 69/1130 4.49E-08 7.27E-06 
ErbB Signaling Pathway 14/87 3.64E-07 2.95E-05 
Tight Junction 16/132 2.77E-06 1.0E-04 
Pathways in Cancer 27/326 3.06E-06 1.0E-04 
T Cell Receptor Signaling Pathway 13/108 2.51E-05 8.0E-04 
Ŧ
P-values are Benjamini-Hochberg adjusted. The top five canonical pathways from IPA and KEGG 
pathways from WebGestalt are displayed.  
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Abbreviations 
1KGP – 1000 Genomes Project 
AMR – Ad Mixed American 
CCT – Central corneal thickness 
CEU – CEPH in Utah residents 
GC – Genomic control 
GLAUGEN – Glaucoma Gene Environment Initiative 
GWAS – Genome-wide association study 
IPA – Ingenuity Pathway Analysis 
KEGG – Kyoto Encyclopedia of Genes and Genomes 
LALES – Los Angeles Latino Eye Study 
LD – Linkage disequilibrium 
MAF – Minor allele frequency 
MAGGS – Mexican American Glaucoma Genetic Study 
NA – Native American 
NEIGHBOR – NEI Glaucoma Human Genetics Collaboration 
POAG – Primary open angle glaucoma 
Q-Q – Quantile-quantile 
SNPs – Single nucleotide polymorphisms 
YRI – Yoruba in Ibadan, Nigeria 
28
Appendix 
Tin Aung
1,2
, Kathryn P. Burdon
3
, Ching-Yu Cheng
1,2
, Jamie E. Craig
4
, Angela J Cree
5
, Puya 
Gharahkhani
6
, Christopher J. Hammond
7
, Alex W. Hewitt
8
, René Höhn
9
, Pirro Hysi
7
, Adriana I Iglesias 
Gonzalez
10
, Jost Jonas
11
, Anthony Khawaja
12,13
, Chiea-Cheun Khor
14
, Caroline CW Klaver
15
, Francesca 
Pasutto
16
, Stuart MacGregor
6
, David Mackey
17
, Paul Mitchell
18
, Aniket Mishra
6
, Calvin Pang
19
, Louis R 
Pasquale
20
, Henriette Springelkamp
15
, Gudmar Thorleifsson
21
, Unnur Thorsteinsdottir
21
, Cornelia M van 
Duijn
22
, Ananth Viswanathan
23
, Veronique Vitart
24
, Janey L Wiggs
20
, Robert Wojciechowski
25,26,27
, Tien 
Wong
1,2
, Terrri L Young
28
, Tanja Zeller
29
 
1
Singapore Eye Research Institute, Singapore National Eye Centre, Singapore; 
2
Department of 
Ophthalmology, National University of Singapore and National University Health System, Singapore; 
3
Menzies Institute for Medical Research, University of Tasmania, Hobart, Tasmania, Australia; 
4
Department of Ophthalmology, Flinders University, Adelaide, Australia; 
5
Clinical & Experimental 
Sciences, Faculty of Medicine, University of Southampton, Southampton, UK; 
6
Statistical Genetics, 
Queensland Institute of Medical Research, Brisbane 4029, Australia; 
7
Department of Twin Research and 
Genetic Epidemiology, King's College London, St. Thomas’ Hospital, London, UK; 
8
Centre for Eye 
Research Australia, University of Melbourne, Royal Victorian Eye and Ear Hospital, Melbourne, 
Australia; 
9
Department of Ophthalmology, University Medical Center Mainz, Mainz, Germany; 
10
Department of Epidemiology, Erasmus University Medical Center, Rotterdam, The Netherlands; 
11
Department of Ophthalmology, Medical Faculty Mannheim of the Ruprecht-Karls-University of 
Heidelberg, Mannheim, Germany;
 12
Department of Public Health and Primary Care, University of 
Cambridge, Cambridge, UK; 
13
NIHR Biomedical Research Centre for Ophthalmology, Moorfields Eye 
Hospital and UCL Institute of Ophthalmology, London, UK; 
14
Department of Human Genetics, Genome 
Institute of Singapore, Singapore; 
15
Department of Epidemiology and Department of Ophthalmology, 
Erasmus Medical Center, Rotterdam, The Netherlands; 
16
Institute of Human Genetics, Friedrich-
Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany; 
17
Centre for Ophthalmology and 
Visual Science, Lions Eye Institute, University of Western Australia, Perth, Australia; 
18
Centre for Vision 
Research, Department of Ophthalmology and Westmead Millennium Institute, University of Sydney, 
Sydney, Australia; 
19
Department of Ophthalmology and Visual Sciences, Chinese University of Hong 
Kong, Hong Kong, China; 
20
Department of Ophthalmology, Harvard Medical School, Massachusetts Eye 
and Ear, Boston, MA; 
21
deCODE Genetics/Amgen, 101 Reykjavik, Iceland; 
22
Department of 
Epidemiology, Erasmus Medical Center, Rotterdam, The Netherlands; 
23
NIHR Biomedical Research 
Centre, Moorfields Eye Hospital NHS Foundation Trust, University College London, Institute of 
Ophthalmology, London, UK; 
24
MRC Human Genetics Unit, IGMM, University of Edinburgh, Edinburgh 
EH4 2XU, UK; 
25
Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, 
Baltimore, MD, USA; 
26
Wilmer Eye Institute, Johns Hopkins School of Medicine, Baltimore, MD, USA; 
27
National Human Genome Research Institute (NIH), Baltimore, MD, USA; 
28
Department of 
Ophthalmology and Visual Sciences, School of Medicine and Public Health, University of Wisconsin, 
Madison, Wisconsin 53705, USA; 
29
Clinic for General and Interventional Cardiology, University Heart 
Center Hamburg, Hamburg, Germany. 
Figure 1 
02
4
6
8
10
−
log
10
(p
−v
alu
e)
0
20
40
60
80
100
Recom
bination rate (cM
/M
b)
●
●
●●
●
●●
●
●●
●
●
●
●●
●●
●
●
●●
●
●
●
●
●
●
●
●
●
●
●
●
●
●●
●
●
●
●●
●
●●
●
●●
●
●●
●
●
●
●
●
●
●
●●
●
●
●
●
●●
●
●●
●
●
●
●
●
●
●
●
●●●
●
●
●
●●
●●●
●
●
●
●
●
●●
●
●●
●
●
●
●
●●●●●
●
●
●
●
●
●
●●
●
●●●
●
●
●●●●●●●●●
●●●
●●
●
●
●
●●
●
●●●●●
●
●●
●●●
●
●
●●
●
●
●
●●
●●
●
●
●
●
●●
●●●
●
●
●
rs10453441
0.2
0.4
0.6
0.8
r2
ATXN10 WNT7B LOC730668
LINC00899
PRR34
LOC150381
MIRLET7BHG
MIR3619
MIRLET7A3
MIR4763
MIRLET7B
PPARA
46.2 46.3 46.4 46.5
Position on chr22 (Mb)
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
